Fundraising FoxHM Venture Partners — 2020 Investments
1 investments dated 2020 · listed companies and verified rows first · show all
OncoC4oncoc4.cominDec 2020
OncoC4 is a clinical-stage biopharmaceutical company developing immunotherapy treatments for cancer patients, based on research by its immunologist founders.
BiotechHealthtechRockville, US
Yang Liu(Co-founder)inPan Zheng(Co-founder)inMartin Devenport(Executive Officer)Michael Flaschen(Director)
Co-investors3E Bioventures Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.